Skip to main content
Top
Published in: Virchows Archiv 4/2016

01-10-2016 | Original Article

HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer

Authors: Anne Tuomisto, José García-Solano, Päivi Sirniö, Juha Väyrynen, Miguel Pérez-Guillermo, Markus J Mäkinen, Pablo Conesa-Zamora

Published in: Virchows Archiv | Issue 4/2016

Login to get access

Abstract

Serrated colorectal adenocarcinoma (SAC) is a morphologically distinct subtype of colorectal cancer (CRC), in which increased HIF-1α mRNA expression and HIF-1α protein stabilization are typical features. Here we aimed to further elucidate HIF-1α protein expression in serrated and non-serrated colorectal carcinomas (CRCs) and their precursor lesions and its association with vascular endothelial growth factor (VEGF) and microvascular density (MVD). HIF-1α and VEGF expressions were determined immunohistochemically in 134 serrated polyps (SPs), 104 non-serrated adenomas (NSAs), 81 SACs, and 74 matched conventional adenocarcinomas (CCs) and were correlated with morphology, clinicopathological features, and MVD. In premalignant lesions, both HIF-1α and VEGF were expressed in the vast majority of SPs and NSAs. In CRCs, HIF-1α protein was also present in 77.8 % of SACs, while only 20.3 % of CCs were HIF-1α proficient. MVD was significantly higher in SACs, but the serrated morphology was the only significant predictor of MVD in CRC in multivariate analyses. HIF-1α protein is often stabilized in well-vascularized SACs, suggesting hypoxia-independent stabilization of HIF-1α. Moreover, HIF-1α stabilization did not associate with oncogenic activation of BRAF or KRAS or Von Hippel-Lindau (VHL) mutation. Prevalent HIF-1α expression in SAC and its precursors support the importance of HIF-1α-mediated pathways for the serrated route of colorectal carcinogenesis.
Appendix
Available only for authorised users
Literature
3.
6.
go back to reference O’Brien MJ, Yang S, Mack C, et al. (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30:1491–1501. doi:10.1097/01.pas.0000213313.36306.85 CrossRefPubMed O’Brien MJ, Yang S, Mack C, et al. (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30:1491–1501. doi:10.​1097/​01.​pas.​0000213313.​36306.​85 CrossRefPubMed
8.
go back to reference García-Solano J, Conesa-Zamora P, Carbonell P, et al. (2012) Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas. Int J Cancer 131:1790–1799. doi:10.1002/ijc.27454 CrossRefPubMed García-Solano J, Conesa-Zamora P, Carbonell P, et al. (2012) Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas. Int J Cancer 131:1790–1799. doi:10.​1002/​ijc.​27454 CrossRefPubMed
9.
go back to reference García-Solano J, Conesa-Zamora P, Trujillo-Santos J, et al. (2011) Tumour budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma. Histopathology 59:1046–1056. doi:10.1111/j.1365-2559.2011.04043.x CrossRefPubMed García-Solano J, Conesa-Zamora P, Trujillo-Santos J, et al. (2011) Tumour budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma. Histopathology 59:1046–1056. doi:10.​1111/​j.​1365-2559.​2011.​04043.​x CrossRefPubMed
10.
go back to reference García-Solano J, Pérez-Guillermo M, Conesa-Zamora P, et al. (2010) Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol 41:1359–1368. doi:10.1016/j.humpath.2010.04.002 CrossRefPubMed García-Solano J, Pérez-Guillermo M, Conesa-Zamora P, et al. (2010) Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol 41:1359–1368. doi:10.​1016/​j.​humpath.​2010.​04.​002 CrossRefPubMed
11.
go back to reference Zhong H, De Marzo AM, Laughner E, et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830–5835PubMed Zhong H, De Marzo AM, Laughner E, et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830–5835PubMed
15.
17.
go back to reference Zhong H, Chiles K, Feldser D, et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541–1545PubMed Zhong H, Chiles K, Feldser D, et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541–1545PubMed
18.
go back to reference Krieg M, Haas R, Brauch H, et al. (2000) Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19:5435–5443. doi:10.1038/sj.onc.1203938 CrossRefPubMed Krieg M, Haas R, Brauch H, et al. (2000) Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19:5435–5443. doi:10.​1038/​sj.​onc.​1203938 CrossRefPubMed
22.
go back to reference Corn PG, Ricci MS, Scata KA, et al. (2005) Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol Ther 4:1285–1294CrossRefPubMed Corn PG, Ricci MS, Scata KA, et al. (2005) Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol Ther 4:1285–1294CrossRefPubMed
23.
go back to reference Conesa-Zamora P, García-Solano J, García-García F, et al. (2013) Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. Int J Cancer 132:297–307. doi:10.1002/ijc.27674 CrossRefPubMed Conesa-Zamora P, García-Solano J, García-García F, et al. (2013) Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. Int J Cancer 132:297–307. doi:10.​1002/​ijc.​27674 CrossRefPubMed
25.
go back to reference Koukourakis MI, Giatromanolaki A, Sivridis E, et al. (2006) Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway—a report of the tumour angiogenesis research group. J Clin Oncol 24:4301–4308. doi:10.1200/JCO.2006.05.9501 CrossRefPubMed Koukourakis MI, Giatromanolaki A, Sivridis E, et al. (2006) Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway—a report of the tumour angiogenesis research group. J Clin Oncol 24:4301–4308. doi:10.​1200/​JCO.​2006.​05.​9501 CrossRefPubMed
26.
go back to reference Righi A, Sarotto I, Casorzo L, et al. (2014) Tumour budding is associated with hypoxia at the advancing front of colorectal cancer. Histopathology. doi:10.1111/his.12602 PubMed Righi A, Sarotto I, Casorzo L, et al. (2014) Tumour budding is associated with hypoxia at the advancing front of colorectal cancer. Histopathology. doi:10.​1111/​his.​12602 PubMed
28.
go back to reference Kuwai T, Kitadai Y, Tanaka S, et al. (2004) Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma: association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1alpha. Cancer Sci 95:149–153CrossRefPubMed Kuwai T, Kitadai Y, Tanaka S, et al. (2004) Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma: association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1alpha. Cancer Sci 95:149–153CrossRefPubMed
29.
go back to reference Miyakis S, Sourvinos G, Liloglou TL, et al. (2000) The von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. Int J Cancer 88:503–505CrossRefPubMed Miyakis S, Sourvinos G, Liloglou TL, et al. (2000) The von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. Int J Cancer 88:503–505CrossRefPubMed
30.
go back to reference Morimoto T, Mitomi H, Saito T, et al. (2014) Distinct profile of HIF1α, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma. J Gastroenterol Hepatol 29:1192–1199. doi:10.1111/jgh.12553 CrossRefPubMed Morimoto T, Mitomi H, Saito T, et al. (2014) Distinct profile of HIF1α, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma. J Gastroenterol Hepatol 29:1192–1199. doi:10.​1111/​jgh.​12553 CrossRefPubMed
Metadata
Title
HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer
Authors
Anne Tuomisto
José García-Solano
Päivi Sirniö
Juha Väyrynen
Miguel Pérez-Guillermo
Markus J Mäkinen
Pablo Conesa-Zamora
Publication date
01-10-2016
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 4/2016
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-016-1988-8

Other articles of this Issue 4/2016

Virchows Archiv 4/2016 Go to the issue